Bernard Zinman

Bernard Zinman

Mount Sinai Hospital
ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 348 publications

Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.

Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.

Journal: Diabetes care
Published: February 06, 2026

One-Hour Oral Glucose Tolerance Test for the Postpartum Reclassification of Women With Hyperglycemia in Pregnancy.

One-Hour Oral Glucose Tolerance Test for the Postpartum Reclassification of Women With Hyperglycemia in Pregnancy.

Journal: Obstetrical & gynecological survey
Published: December 30, 2025

Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.

Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.

Journal: The New England journal of medicine
Published: December 17, 2025

Evaluation of new staging schema for the early diagnosis of dysglycaemia.

Evaluation of new staging schema for the early diagnosis of dysglycaemia.

Journal: The lancet. Diabetes & endocrinology
Published: November 06, 2025

Exenatide induces an enhanced endogenous glucagon-like peptide-1 secretory response in patients receiving basal insulin.

Exenatide induces an enhanced endogenous glucagon-like peptide-1 secretory response in patients receiving basal insulin.

Journal: The Journal of clinical endocrinology and metabolism
Published: October 31, 2025

Exenatide induces an Enhanced Endogenous Glucagon-like Peptide-1 Secretory Response in Patients receiving Basal Insulin.

Exenatide induces an Enhanced Endogenous Glucagon-like Peptide-1 Secretory Response in Patients receiving Basal Insulin.

Journal: The Journal of clinical endocrinology and metabolism
Published: October 31, 2025

A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial.

A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial.

Journal: The lancet. Diabetes & endocrinology
Published: October 14, 2025

Impact of an Additional Pregnancy on the Natural History of Insulin Sensitivity, β-Cell Function, and Glycemia in Parous Women.

Impact of an Additional Pregnancy on the Natural History of Insulin Sensitivity, β-Cell Function, and Glycemia in Parous Women.

Journal: Diabetes care
Published: September 23, 2025

Empagliflozin for the preservation of beta-cell function in women with recent gestational diabetes: A randomized placebo-controlled trial.

Empagliflozin for the preservation of beta-cell function in women with recent gestational diabetes: A randomized placebo-controlled trial.

Journal: Diabetes, obesity & metabolism
Published: July 18, 2025

Serum endotrophin relates to blood pressure in young South Asian women but not White women: evidence of ethnic variation in its early vascular implications.

Serum endotrophin relates to blood pressure in young South Asian women but not White women: evidence of ethnic variation in its early vascular implications.

Journal: BMC cardiovascular disorders
Published: May 16, 2025

A1c versus oral glucose tolerance test for chronic glycemic surveillance in women with previous gestational diabetes.

A1c versus oral glucose tolerance test for chronic glycemic surveillance in women with previous gestational diabetes.

Journal: Diabetes, obesity & metabolism
Published: April 18, 2025

The central role of recovery of β-cell function in the remission of prediabetes: a prospective cohort study in Canada.

The central role of recovery of β-cell function in the remission of prediabetes: a prospective cohort study in Canada.

Journal: The lancet. Diabetes & endocrinology
Published: March 04, 2025
Showing 1-12 of 348

Last Updated: 09/26/2026